173 related articles for article (PubMed ID: 11911408)
1. Second malignancies after treatment for Hodgkin's disease.
Várady E; Deák B; Molnár ZS; Rosta A; Schneider T; Esik O; Eckhardt S
Leuk Lymphoma; 2001; 42(6):1275-81. PubMed ID: 11911408
[TBL] [Abstract][Full Text] [Related]
2. [Second malignant disease in patients under treatment for malignant lymphoma].
Várady E; Molnár Z; Schneider T; Fleischmann T
Orv Hetil; 1995 Oct; 136(43):2323-8. PubMed ID: 7478476
[TBL] [Abstract][Full Text] [Related]
3. Second malignancies after Hodgkin's disease: the Munich experience.
Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
[TBL] [Abstract][Full Text] [Related]
4. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
[TBL] [Abstract][Full Text] [Related]
6. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
Beaty O; Hudson MM; Greenwald C; Luo X; Fang L; Wilimas JA; Thompson EI; Kun LE; Pratt CB
J Clin Oncol; 1995 Mar; 13(3):603-9. PubMed ID: 7884422
[TBL] [Abstract][Full Text] [Related]
7. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
8. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
[TBL] [Abstract][Full Text] [Related]
9. [Second malignancies in patients treated for Hodgkin's disease].
Keresztes K; Miltényi Z; András C; Illés A
Magy Onkol; 2002; 46(3):247-51. PubMed ID: 12368920
[TBL] [Abstract][Full Text] [Related]
10. Second cancers following pediatric Hodgkin's disease.
Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
[TBL] [Abstract][Full Text] [Related]
11. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
[TBL] [Abstract][Full Text] [Related]
12. Leukemia as a second malignancy.
Uppin MS; Paul TR; Rajappa S; Gayathri K; Jacob R; Uppin SG
Indian J Pathol Microbiol; 2007 Jul; 50(3):644-7. PubMed ID: 17883171
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease: complications of therapy and excess mortality.
Hoppe RT
Ann Oncol; 1997; 8 Suppl 1():115-8. PubMed ID: 9187444
[TBL] [Abstract][Full Text] [Related]
14. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.
Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Abrahamsen AF; Kvaløy S; Høst H
J Clin Oncol; 1993 Feb; 11(2):255-61. PubMed ID: 8426202
[TBL] [Abstract][Full Text] [Related]
15. [Second malignancies after the therapy of Hodgkin's disease: the Freiburg collective 1940 to 1991].
Slanina J; Heinemann F; Henne K; Moog G; Frommhold H
Strahlenther Onkol; 1999 Apr; 175(4):154-61. PubMed ID: 10230457
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time.
Foss Abrahamsen A; Andersen A; Nome O; Jacobsen AB; Holte H; Foss Abrahamsen J; Kvaløy S
Ann Oncol; 2002 Nov; 13(11):1786-91. PubMed ID: 12419752
[TBL] [Abstract][Full Text] [Related]
17. Solid second cancers following Hodgkin's disease.
Tucker MA
Hematol Oncol Clin North Am; 1993 Apr; 7(2):389-400. PubMed ID: 8468272
[TBL] [Abstract][Full Text] [Related]
18. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
19. [Hodgkin's lymphoma and secondary leukemias].
Centurioni R; Brianzoni MF; Salvi A; Montillo M; Rupoli S; Olivieri A; Leoni P; Danieli G
Recenti Prog Med; 1993 May; 84(5):328-35. PubMed ID: 8511392
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the risk of solid tumor following Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]